Rosenbaum J T, Robertson J E
Casey Eye Institute Oregon Health Sciences University, Portland 97201.
Retina. 1993;13(1):17-21. doi: 10.1097/00006982-199313010-00005.
Posterior scleritis is a rare disease, the clinical signs of which may vary. There is no consensus on the appropriate method of treatment for this disease. Some have advocated treatment with nonsteroidal antiinflammatory drugs, whereas others have reported variable success with potentially more toxic therapy. Patients with posterior scleritis constitute approximately 1% of the uveitis clinic population at the Casey Eye Institute in Portland, Oregon. The cases of 6 patients with posterior scleritis, the diagnosis of which was elusive, are reported. Posterior scleritis was generally confirmed by ultrasound examination. Each of the patients responded to treatment with indomethacin, which was usually the sole method of nontopical therapy. Thus, recognition of this relatively rare disease had marked implications for treatment.
后巩膜炎是一种罕见疾病，其临床症状可能各不相同。对于该疾病的恰当治疗方法尚无共识。一些人主张使用非甾体类抗炎药进行治疗，而另一些人则报告称，使用潜在毒性更大的疗法取得了不同程度的成功。在俄勒冈州波特兰市的凯西眼科研究所，后巩膜炎患者约占葡萄膜炎门诊患者的1%。本文报告了6例诊断困难的后巩膜炎病例。后巩膜炎通常通过超声检查得以确诊。每位患者对吲哚美辛治疗均有反应，吲哚美辛通常是唯一的非局部治疗方法。因此，认识到这种相对罕见的疾病对治疗具有重要意义。
